# C_2016182EN.01000601.xml

| 20.5.2016 | EN | Official Journal of the European Union | C 182/6 |
| --- | --- | --- | --- |

20.5.2016

EN

Official Journal of the European Union

C 182/6

---

Prior notification of a concentration

(Case M.8029 — KNB/Mitsui/DVHP/DaVita)

Candidate case for simplified procedure

(Text with EEA relevance)

(2016/C 182/07)

| 1. | On 10 May 2016, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Khazanah Nasional Berhad (‘Khazanah’, Malaysia), Mitsui & Co., Ltd (‘Mitsui’, Japan) and DaVita Healthcare Partners Inc. (‘DVHP’, United States), through its wholly-owned subsidiary, DV Care Netherlands BV (‘DVBV’), acquires within the meaning of Article 3(1)(b) and Article 3(4) of the Merger Regulation joint control of the undertaking DaVita Care Pte. Ltd (‘DaVita’, Singapore) by way of purchase of shares. |
| --- | --- |

1.

On 10 May 2016, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Khazanah Nasional Berhad (‘Khazanah’, Malaysia), Mitsui & Co., Ltd (‘Mitsui’, Japan) and DaVita Healthcare Partners Inc. (‘DVHP’, United States), through its wholly-owned subsidiary, DV Care Netherlands BV (‘DVBV’), acquires within the meaning of Article 3(1)(b) and Article 3(4) of the Merger Regulation joint control of the undertaking DaVita Care Pte. Ltd (‘DaVita’, Singapore) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:
  —   for Khazanah: Khazanah is headquartered in Kuala Lumpur, Malaysia and is the Government of Malaysia’s strategic investment fund,
  —   for Mitsui: Mitsui is a Japanese trading house engaged in various worldwide commodity and other businesses,
  —   for DVHP: DVHP, headquartered in the United States and publicly listed on the New York Stock Exchange, provides a variety of healthcare services,
  —   for DaVita: DaVita Care Pte. Ltd, operates local dialysis centres and provides hospital management consultation services related to kidney care/dialysis in five countries in Asia: Singapore, Malaysia, India, China and Taiwan. |
| --- | --- |

2.

The business activities of the undertakings concerned are:

—   for Khazanah: Khazanah is headquartered in Kuala Lumpur, Malaysia and is the Government of Malaysia’s strategic investment fund,

for Khazanah

—   for Mitsui: Mitsui is a Japanese trading house engaged in various worldwide commodity and other businesses,

for Mitsui

—   for DVHP: DVHP, headquartered in the United States and publicly listed on the New York Stock Exchange, provides a variety of healthcare services,

for DVHP

—   for DaVita: DaVita Care Pte. Ltd, operates local dialysis centres and provides hospital management consultation services related to kidney care/dialysis in five countries in Asia: Singapore, Malaysia, India, China and Taiwan.

for DaVita

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in this Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in this Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.8029 — KNB/Mitsui/DVHP/DaVita, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.8029 — KNB/Mitsui/DVHP/DaVita, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---